Cue Biopharma, Inc. Patent Application Trends in 2024

From WikiPatents

Jump to navigation Jump to search

Contents

1 Cue Biopharma, Inc. Patent Filing Activity
2 Cue Biopharma, Inc. patent applications in 2024
3 Top 10 Technology Areas
4 Emerging Technology Areas
5 Top Inventors
6 Patent Categories
7 Geographical Distribution of Inventors
8 Geographical Distribution of US Inventors

Cue Biopharma, Inc. Patent Filing Activity

Cue Biopharma, Inc. patent applications in 2024

Top 10 Technology Areas

C07K14/70539 (No explanation available)
- Count: 14 patents
- Example: 20240101627. MHC CLASS II T-CELL MODULATORY POLYPEPTIDES FOR TREATING TYPE 1 DIABETES MELLITUS (T1D) AND METHODS OF USE THEREOF simplified abstract (Cue Biopharma, Inc.)
C07K14/55 (No explanation available)
- Count: 11 patents
- Example: 20240101627. MHC CLASS II T-CELL MODULATORY POLYPEPTIDES FOR TREATING TYPE 1 DIABETES MELLITUS (T1D) AND METHODS OF USE THEREOF simplified abstract (Cue Biopharma, Inc.)
A61K38/00 (No explanation available)
- Count: 8 patents
- Example: 20240101627. MHC CLASS II T-CELL MODULATORY POLYPEPTIDES FOR TREATING TYPE 1 DIABETES MELLITUS (T1D) AND METHODS OF USE THEREOF simplified abstract (Cue Biopharma, Inc.)
C07K2319/30 (No explanation available)
- Count: 6 patents
- Example: 20240181025. Antigen Presenting Polypeptide Complexes Bearing TGF-Beta and Methods of Use Thereof simplified abstract (Cue Biopharma, Inc.)
C07K14/495 (No explanation available)
- Count: 5 patents
- Example: 20240101627. MHC CLASS II T-CELL MODULATORY POLYPEPTIDES FOR TREATING TYPE 1 DIABETES MELLITUS (T1D) AND METHODS OF USE THEREOF simplified abstract (Cue Biopharma, Inc.)
A61K9/0019 (No explanation available)
- Count: 5 patents
- Example: 20240199715. T-CELL MODULATORY MULTIMERIC POLYPEPTIDES AND METHODS OF USE THEREOF simplified abstract (Cue Biopharma, Inc.)
C07K14/005 (No explanation available)
- Count: 5 patents
- Example: 20240199715. T-CELL MODULATORY MULTIMERIC POLYPEPTIDES AND METHODS OF USE THEREOF simplified abstract (Cue Biopharma, Inc.)
A61K39/0008 (No explanation available)
- Count: 4 patents
- Example: 20240181025. Antigen Presenting Polypeptide Complexes Bearing TGF-Beta and Methods of Use Thereof simplified abstract (Cue Biopharma, Inc.)
A61K35/17 (No explanation available)
- Count: 4 patents
- Example: 20240199715. T-CELL MODULATORY MULTIMERIC POLYPEPTIDES AND METHODS OF USE THEREOF simplified abstract (Cue Biopharma, Inc.)
C07K14/4748 (No explanation available)
- Count: 4 patents
- Example: 20240199715. T-CELL MODULATORY MULTIMERIC POLYPEPTIDES AND METHODS OF USE THEREOF simplified abstract (Cue Biopharma, Inc.)

Emerging Technology Areas

C40B40/10 (No explanation available)
- Count: 1 patents
- Example: 20240025964. MULTIMERIC T-CELL MODULATORY POLYPEPTIDES AND METHODS OF USE THEREOF simplified abstract (Cue Biopharma, Inc.)
C07K16/2833 (No explanation available)
- Count: 1 patents
- Example: 20240025964. MULTIMERIC T-CELL MODULATORY POLYPEPTIDES AND METHODS OF USE THEREOF simplified abstract (Cue Biopharma, Inc.)
A61K2039/645 (No explanation available)
- Count: 1 patents
- Example: 20240082411. T-Cell Modulatory Polypeptides with Conjugation Sites and Methods of Use Thereof simplified abstract (Cue Biopharma, Inc.)
C07K14/70575 (No explanation available)
- Count: 1 patents
- Example: 20240190933. Antigen Presenting Polypeptide Complexes Bearing TGF-Beta and Methods of Use Thereof simplified abstract (Cue Biopharma, Inc.)
A61K47/6425 (No explanation available)
- Count: 1 patents
- Example: 20240189437. MULTIMERIC T-CELL MODULATORY POLYPEPTIDES AND METHODS OF USE THEREOF simplified abstract (Cue Biopharma, Inc.)
A61K47/642 (No explanation available)
- Count: 1 patents
- Example: 20240189437. MULTIMERIC T-CELL MODULATORY POLYPEPTIDES AND METHODS OF USE THEREOF simplified abstract (Cue Biopharma, Inc.)
A61K39/001153 (No explanation available)
- Count: 1 patents
- Example: 20240189437. MULTIMERIC T-CELL MODULATORY POLYPEPTIDES AND METHODS OF USE THEREOF simplified abstract (Cue Biopharma, Inc.)
A61K39/001114 (No explanation available)
- Count: 1 patents
- Example: 20240189437. MULTIMERIC T-CELL MODULATORY POLYPEPTIDES AND METHODS OF USE THEREOF simplified abstract (Cue Biopharma, Inc.)
C07K2318/20 (No explanation available)
- Count: 1 patents
- Example: 20240189403. Antigen-Presenting Polypeptides with Chemical Conjugation Sites and Methods of Use Thereof simplified abstract (Cue Biopharma, Inc.)
C07K2318/10 (No explanation available)
- Count: 1 patents
- Example: 20240189403. Antigen-Presenting Polypeptides with Chemical Conjugation Sites and Methods of Use Thereof simplified abstract (Cue Biopharma, Inc.)

Top Inventors

Ronald D. Seidel, III of Boston MA (US) (12 patents)
Rodolfo J. Chaparro of Cambridge MA (US) (12 patents)
Ronald D. SEIDEL, III of Natick MA (US) (5 patents)
John F. ROSS of Arlington MA (US) (5 patents)
Chee Meng LOW of Cambridge MA (US) (4 patents)
John F. Ross of Boston MA (US) (4 patents)
Saso Cemerski of Boston MA (US) (4 patents)
Chee Meng Low of Boston MA (US) (3 patents)
Anish Suri of Boston MA (US) (1 patent)
Raymond J. Moniz of Boston MA (US) (1 patent)

Patent Categories

Geographical Distribution of Inventors

Geographical Distribution of US Inventors

Retrieved from "http://wikipatents.org/index.php?title=Cue_Biopharma,_Inc._Patent_Application_Trends_in_2024&oldid=115592"